Search Results - "Nucci, Fabio"
-
1
BIOF–HILO Assay: A New MALDI–TOF Mass Spectrometry Based Method for Discriminating Between High- and Low-Biofilm-Producing Candida parapsilosis Isolates
Published in Frontiers in microbiology (30-08-2019)“…Candida parapsilosis is the most frequent cause of catheter-related candidemia among non- Candida albicans species. This may be related to intrinsic…”
Get full text
Journal Article -
2
COVID-19 in chronic myeloid leukemia patients in Latin America
Published in Leukemia & lymphoma (10-11-2021)“…This observational, multicenter study aimed to report the clinical evolution of COVID-19 in patients with chronic myeloid leukemia in Latin America. A total of…”
Get full text
Journal Article -
3
Fusariosis
Published in Seminars in respiratory and critical care medicine (01-10-2015)“…Fusarium species are frequent agents of onychomycosis and fungal keratitis, and occasional agents of invasive disease. The clinical spectrum of fusariosis in…”
Get more information
Journal Article -
4
Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study
Published in Leukemia & lymphoma (10-09-2024)“…Duodenal-type follicular lymphoma (DFL) is a rare subtype classified by the 5th edition of the WHO and international consensus classifications of lymphoid…”
Get full text
Journal Article -
5
-
6
COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience
Published in Blood (05-11-2020)“…▪ Coronavirus disease (COVID-19) is an infectious disease caused by the newly discovered coronavirus Sars-Cov2. In Brazil, the first COVID-19 case was…”
Get full text
Journal Article -
7
Brazilian Real-World Multiple Myeloma (MM) Electronic Platform Register Project
Published in Blood (05-11-2020)“…Introduction: An epidemiological database is an important tool to characterize the population disease distribution, long-term effects of the diseases, impact…”
Get full text
Journal Article -
8
Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?
Published in Mycoses (01-05-2019)“…Summary Background Patients treated for invasive aspergillosis may relapse during subsequent periods of immunosuppression and should receive secondary…”
Get full text
Journal Article